Skip to main content
Erschienen in: Clinical & Experimental Metastasis 5/2008

01.09.2008 | Research Paper

Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis

verfasst von: Linda Sequeira, Cara W. Dubyk, Tracy A. Riesenberger, Carlton R. Cooper, Kenneth L. van Golen

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Background The Rho GTPases comprise one of the eight subfamilies of the Ras superfamily of monomeric GTP-binding proteins and are involved in cytoskeletal organization. Previously, using a dominant negative construct, we demonstrated a role for RhoC GTPase in conferring invasive capabilities to PC-3 human prostate cancer cells. Further, we demonstrated that inactivation of RhoC led to morphological changes commensurate with epithelial to mesenchymal transition (EMT) and was accompanied by increased random, linear motility and decreased directed migration and invasion. EMT was related positively to sustained expression and activity of Rac GTPase. In the current study we analyze the individual roles of RhoA, RhoC and Rac1 GTPases in PC-3 cell directed migration, invasion and tumor cell diapedesis across a human bone marrow endothelial cell layer in vitro. Results Use of specific shRNA directed against RhoA, RhoC or Rac1 GTPases demonstrated a role for each protein in maintaining cell morphology. Furthermore, we demonstrate that RhoC expression and activation is required for directed migration and invasion, while Rac1 expression and activation is required for tumor cell diapedesis. Inhibition of RhoA expression produced a slight increase in invasion and tumor cell diapedesis. Conclusions Individual Rho GTPases are required for critical aspects of migration, invasion and tumor cell diapedesis. These data suggest that coordinated activation of individual Rho proteins is required for cells to successfully complete the extravasation process; a key step in distant metastasis.
Literatur
1.
Zurück zum Zitat American Cancer Society (2008) Cancer facts & figures 2008 American Cancer Society (2008) Cancer facts & figures 2008
2.
Zurück zum Zitat Alcover J, Fernandez-Conde M, Carrere W, Serrallach M, Carretero P (1994) Treatment of tumor osteopathy in cancer of the prostate. Actas Urol Esp 18(Suppl):409–416PubMed Alcover J, Fernandez-Conde M, Carrere W, Serrallach M, Carretero P (1994) Treatment of tumor osteopathy in cancer of the prostate. Actas Urol Esp 18(Suppl):409–416PubMed
4.
Zurück zum Zitat Aukerman SL, Price JE, Fidler IJ (1986) Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases. J Natl Cancer Inst 77:915–924PubMed Aukerman SL, Price JE, Fidler IJ (1986) Different deficiencies in the prevention of tumorigenic-low-metastatic murine K-1735b melanoma cells from producing metastases. J Natl Cancer Inst 77:915–924PubMed
5.
Zurück zum Zitat Price JE, Aukerman SL, Fidler IJ (1986) Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res 46:5172–5178PubMed Price JE, Aukerman SL, Fidler IJ (1986) Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res 46:5172–5178PubMed
7.
Zurück zum Zitat Cooper CR, McLean L, Walsh M et al (2000) Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clin Cancer Res 6:4839–4847PubMed Cooper CR, McLean L, Walsh M et al (2000) Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clin Cancer Res 6:4839–4847PubMed
15.
17.
Zurück zum Zitat West K, Zhang H, Brown M et al (2004) The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol 154:161–176. doi:10.1083/jcb.200101039 CrossRef West K, Zhang H, Brown M et al (2004) The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol 154:161–176. doi:10.​1083/​jcb.​200101039 CrossRef
19.
Zurück zum Zitat Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD (2002) Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160:579–584PubMed Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD (2002) Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160:579–584PubMed
21.
Zurück zum Zitat van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD (2000) RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60:5832–5838PubMed van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD (2000) RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60:5832–5838PubMed
26.
Zurück zum Zitat Takai Y, Sasaki T, Matozaki T (2001) Small GTP-binding proteins. Physiol Rev 81:153–208PubMed Takai Y, Sasaki T, Matozaki T (2001) Small GTP-binding proteins. Physiol Rev 81:153–208PubMed
29.
Zurück zum Zitat van Golen KL, Davies S, Wu ZF et al (1999) A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5:2511–2519PubMed van Golen KL, Davies S, Wu ZF et al (1999) A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5:2511–2519PubMed
30.
Zurück zum Zitat Suwa H, Ohshio G, Imamura T et al (1998) Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77:147–152PubMed Suwa H, Ohshio G, Imamura T et al (1998) Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77:147–152PubMed
34.
Zurück zum Zitat Moscow JA, He R, Gnarra JR et al (1994) Examination of human tumors for rhoA mutations. Oncogene 9:189–194PubMed Moscow JA, He R, Gnarra JR et al (1994) Examination of human tumors for rhoA mutations. Oncogene 9:189–194PubMed
36.
Zurück zum Zitat Marionnet C, Lalou C, Mollier K et al (2003) Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development. Oncogene 22:3500–3505. doi:10.1038/sj.onc.1206571 PubMedCrossRef Marionnet C, Lalou C, Mollier K et al (2003) Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development. Oncogene 22:3500–3505. doi:10.​1038/​sj.​onc.​1206571 PubMedCrossRef
37.
Zurück zum Zitat Horiuchi A, Imai T, Wang C et al (2003) Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83:861–870PubMed Horiuchi A, Imai T, Wang C et al (2003) Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83:861–870PubMed
38.
Zurück zum Zitat Kamai T, Tsujii T, Arai K et al (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9:2632–2641PubMed Kamai T, Tsujii T, Arai K et al (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9:2632–2641PubMed
39.
Zurück zum Zitat Shinto E, Tsuda H, Matsubara O, Mochizuki H (2003) Significance of RhoC expression in terms of invasion and metastasis of colorectal cancer. Nippon Rinsho 61(Suppl 7):215–219PubMed Shinto E, Tsuda H, Matsubara O, Mochizuki H (2003) Significance of RhoC expression in terms of invasion and metastasis of colorectal cancer. Nippon Rinsho 61(Suppl 7):215–219PubMed
40.
Zurück zum Zitat Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ (2003) Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 9:1950–1953PubMed Wang W, Yang LY, Yang ZL, Huang GW, Lu WQ (2003) Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol 9:1950–1953PubMed
41.
42.
Zurück zum Zitat Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG (1999) Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 147:1009–1022. doi:10.1083/jcb.147.5.1009 PubMedCrossRef Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG (1999) Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 147:1009–1022. doi:10.​1083/​jcb.​147.​5.​1009 PubMedCrossRef
45.
Zurück zum Zitat Arthur WT, Burridge K (2001) RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 12:2711–2720PubMed Arthur WT, Burridge K (2001) RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 12:2711–2720PubMed
51.
Zurück zum Zitat Sahai E, Marshall CJ (2003) Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5:711–719. doi:10.1038/ncb1019 PubMedCrossRef Sahai E, Marshall CJ (2003) Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5:711–719. doi:10.​1038/​ncb1019 PubMedCrossRef
Metadaten
Titel
Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis
verfasst von
Linda Sequeira
Cara W. Dubyk
Tracy A. Riesenberger
Carlton R. Cooper
Kenneth L. van Golen
Publikationsdatum
01.09.2008
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 5/2008
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-008-9173-3

Weitere Artikel der Ausgabe 5/2008

Clinical & Experimental Metastasis 5/2008 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.